Hilde Vanaken - R&D Operations Innovation Director, Janssen
Short description of the presentation:
The old-fashioned approach to clinical trials is costly and inefficient, which contributes to escalating drug development costs and late-stage clinical trial failures. This presentation will describe how modern technology and streamlined processes can transform the entire clinical trial process and enable end-to-end patient engagement. eMeds is a program existing of an integrated platform, smart packages and mobile devices which will automate clinical supplies, transform data management and provide personalized patient support, ensuring the right pill for the right patient at the right time. The platform is also designed in an open and cross-industry format, soon accessible for all pharma companies, and is just the first step in an exciting journey to integrate clinical trials in patients’ life and enabling novel clinical trial models.
Biography of the speaker:
Hilde is a Director of the R&D Operations Innovation department at Janssen. She has more than 16 years of experience in pharmaceutical companies and Clinical Research Organizations, where she held various leading positions in clinical operations, data management, safety management, professional affairs, quality management, strategic business improvement and clinical trial innovation. Prior to clinical research, Hilde worked as a research scientist for 6 years.
Hilde has a passion for complex or so called mission impossible projects and has a track record to transform them into success stories. In her current role, she is leading several transformational projects, such as eMeds/ iSTEP (Integrated Smart Trial and Engagement Platform), to modernize Janssen’s clinical trials and improve the experience of patients and investigators. Next to her role in Janssen, Hilde also leads the cross-pharma Transcelerate eConsent initiative to facilitate the cross-industry adoption of eConsent in close collaboration with external stakeholders such as patients, sites, Ethics Committees and Health Authorities.
Hilde holds a degree in Engineering in Chemical and Agricultural Sciences, a Master in Environmental Sciences and a PhD in Medical Sciences, all from the Catholic University of Leuven in Belgium.